These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31391351)
1. Strategies to Overcome Residual Risk During Statins Era. Cho KI; Yu J; Hayashi T; Han SH; Koh KK Circ J; 2019 Sep; 83(10):1973-1979. PubMed ID: 31391351 [TBL] [Abstract][Full Text] [Related]
2. Statins in cardiometabolic disease: what makes pitavastatin different? Ginsberg H Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S1. PubMed ID: 23819727 [TBL] [Abstract][Full Text] [Related]
3. Statins. Ratchford EV; Martin SS Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537 [No Abstract] [Full Text] [Related]
4. Emerging views of statin pleiotropy and cholesterol lowering. Yu D; Liao JK Cardiovasc Res; 2022 Jan; 118(2):413-423. PubMed ID: 33533892 [TBL] [Abstract][Full Text] [Related]
5. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS). Blom DJ; Raal F; Amod A; Naidoo P; Lai YE; Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848 [TBL] [Abstract][Full Text] [Related]
6. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254 [TBL] [Abstract][Full Text] [Related]
7. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359 [TBL] [Abstract][Full Text] [Related]
8. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. Aguiar C; Alegria E; Bonadonna RC; Catapano AL; Cosentino F; Elisaf M; Farnier M; Ferrières J; Filardi PP; Hancu N; Kayikcioglu M; Mello E Silva A; Millan J; Reiner Ž; Tokgozoglu L; Valensi P; Viigimaa M; Vrablik M; Zambon A; Zamorano JL; Ferrari R Atheroscler Suppl; 2015 Sep; 19():1-12. PubMed ID: 26315511 [TBL] [Abstract][Full Text] [Related]
9. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk. Shapiro MD; Fazio S Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970 [TBL] [Abstract][Full Text] [Related]
10. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey. Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D; Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002 [TBL] [Abstract][Full Text] [Related]
11. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes. Khan SU; Talluri S; Riaz H; Rahman H; Nasir F; Bin Riaz I; Sattur S; Ahmed H; Kaluski E; Krasuski R Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492 [TBL] [Abstract][Full Text] [Related]
12. HDL-C: role as a risk modifier. Barter P Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280 [TBL] [Abstract][Full Text] [Related]
13. Statins: Are they really all the same? Cortese F Curr Vasc Pharmacol; 2019; 17(3):211-212. PubMed ID: 30003860 [No Abstract] [Full Text] [Related]
14. Nonadherence to statins: individualized intervention strategies outside the pill box. Lansberg P; Lee A; Lee ZV; Subramaniam K; Setia S Vasc Health Risk Manag; 2018; 14():91-102. PubMed ID: 29872306 [TBL] [Abstract][Full Text] [Related]
15. Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy. Hyun MH; Lee Y; Choi BG; Na JO; Choi CU; Kim JW; Kim EJ; Rha SW; Park CG; Lee E; Seo HS Cardiovasc Ther; 2019; 2019():3824823. PubMed ID: 31885691 [TBL] [Abstract][Full Text] [Related]